| Filed On | Filing |
|---|---|
| 08 Oct 2026 | SCHEDULE 13G/A |
| 06 Oct 2026 |
8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
THIRD AMENDED AND RESTATED BY-LAWS of VTV THERAPEUTICS INC. (A Delaware Corporation) TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 ARTICLE 2 STOCKHOLDERS 3 ARTICLE 3 DIRECTORS 9 ARTICLE 4 COMMITTEES OF THE BOARD 15 ARTICLE 5 OFFICERS 15... |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 29 Jul 2026 | SCHEDULE 13G/A |
| 29 Jun 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Granted 12,000 Non-Qualified Stock Option (right to buy) |
| 29 Jun 2026 |
Form 4: Spiegelman Daniel K, Director
Granted 6,000 Director stock option (right to buy) ($210K) |
| 29 Jun 2026 |
Form 4: Akkaraju Srinivas, Director
Granted 6,000 Director stock option (right to buy) ($210K) |
| 29 Jun 2026 |
Form 4: Al-Marzooqi Fahed, Director
Granted 6,000 Director stock option (right to buy) ($210K) |
| 29 Jun 2026 |
Form 4: Phillips Anne M., Director
Granted 6,000 Director stock option (right to buy) ($210K) |
| 29 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 10 Jun 2026 | DEFA14A |
| 13 May 2026 | 424B2 |
| 13 May 2026 | S-8 |
| 13 May 2026 | 8-K: Other Events |
| 13 May 2026 | 10-Q |
| 13 May 2026 | 8-K: Results of Operations and Financial Condition |
| 28 Apr 2026 |
Proxy statement: annual meeting on June 10, 2026
CEO pay $6.6M, up 72% |
| 16 Apr 2026 | SCHEDULE 13G/A |
| 27 Mar 2026 | SCHEDULE 13G |
Loading...
